Neuroinflammatory mediator

Neuroinflammatory mediators are a diverse set of molecules—including cytokines (such as IL-1β, IL-6, TNF-α), chemokines (such as CCL2/MCP-1, CX3CL1), complement proteins, secondary messengers (NO, prostaglandins), and reactive oxygen species—produced by microglia, astrocytes, endothelial cells, and peripheral immune cells to coordinate inflammation within the central nervous system (CNS). They regulate immune cell recruitment, BBB permeability, neuronal survival and death, synaptic pruning, and neurodevelopment. Dysregulated mediator activity drives neuroinflammatory pathology associated with neurodegeneration, traumatic injury, infection, and autoimmune demyelination. Targeting individual mediators (such as TNF-α, IL-6, and complement factors) is an area of therapeutic interest, but the class as a whole is not a defined molecular target. "Neuroinflammatory mediators" is not a specific molecule or receptor but an umbrella term for various molecular signals. While individual mediators within this group (e.g., IL-6, TNF-α, CCL2, C3) are therapeutic targets, the term itself is generic and not suitable for precise molecular targeting or structural database entries. This entry is too broad for structured molecular targeting—identify individual mediators (like “Tumor necrosis factor-alpha” or “Interleukin-6”) for more accurate information.

Other names

Inflammatory mediator of the nervous systemCNS inflammatory mediator